Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

País de afiliación
Intervalo de año de publicación
1.
Braz. j. med. biol. res ; 47(11): 947-959, 11/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-723898

RESUMEN

This study aimed to investigate the therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia (MFH) using Fe2O3 nanoparticles. Hepatocarcinoma SMMC-7721 cells cultured in vitro were treated with ferrofluid containing Fe2O3 nanoparticles and irradiated with an alternating radio frequency magnetic field. The influence of the treatment on the cells was examined by inverted microscopy, MTT and flow cytometry. To study the therapeutic mechanism of the Fe2O3 MFH, Hsp70, Bax, Bcl-2 and p53 were detected by immunocytochemistry and reverse transcription polymerase chain reaction (RT-PCR). It was shown that Fe2O3 MFH could cause cellular necrosis, induce cellular apoptosis, and significantly inhibit cellular growth, all of which appeared to be dependent on the concentration of the Fe2O3 nanoparticles. Immunocytochemistry results showed that MFH could induce high expression of Hsp70 and Bax, decrease the expression of mutant p53, and had little effect on Bcl-2. RT-PCR indicated that Hsp70 expression was high in the early stage of MFH (<24 h) and became low or absent after 24 h of MFH treatment. It can be concluded that Fe2O3 MFH significantly inhibited the proliferation of in vitro cultured liver cancer cells (SMMC-7721), induced cell apoptosis and arrested the cell cycle at the G2/M phase. Fe2O3 MFH can induce high Hsp70 expression at an early stage, enhance the expression of Bax, and decrease the expression of mutant p53, which promotes the apoptosis of tumor cells.


Asunto(s)
Humanos , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/terapia , Compuestos Férricos/uso terapéutico , Hipertermia Inducida/métodos , Neoplasias Hepáticas/terapia , Magnetoterapia/métodos , Nanopartículas/uso terapéutico , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Carcinoma Hepatocelular/patología , Proliferación Celular/efectos de los fármacos , Citometría de Flujo , Hematínicos/uso terapéutico , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Neoplasias Hepáticas/patología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
2.
Braz J Med Biol Res ; 47(11): 947-59, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25296356

RESUMEN

This study aimed to investigate the therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia (MFH) using Fe2O3 nanoparticles. Hepatocarcinoma SMMC-7721 cells cultured in vitro were treated with ferrofluid containing Fe2O3 nanoparticles and irradiated with an alternating radio frequency magnetic field. The influence of the treatment on the cells was examined by inverted microscopy, MTT and flow cytometry. To study the therapeutic mechanism of the Fe2O3 MFH, Hsp70, Bax, Bcl-2 and p53 were detected by immunocytochemistry and reverse transcription polymerase chain reaction (RT-PCR). It was shown that Fe2O3 MFH could cause cellular necrosis, induce cellular apoptosis, and significantly inhibit cellular growth, all of which appeared to be dependent on the concentration of the Fe2O3nanoparticles. Immunocytochemistry results showed that MFH could induce high expression of Hsp70 and Bax, decrease the expression of mutant p53, and had little effect on Bcl-2. RT-PCR indicated that Hsp70 expression was high in the early stage of MFH (<24 h) and became low or absent after 24 h of MFH treatment. It can be concluded that Fe2O3MFH significantly inhibited the proliferation of in vitro cultured liver cancer cells (SMMC-7721), induced cell apoptosis and arrested the cell cycle at the G2/M phase. Fe2O3 MFH can induce high Hsp70 expression at an early stage, enhance the expression of Bax, and decrease the expression of mutant p53, which promotes the apoptosis of tumor cells.


Asunto(s)
Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/terapia , Compuestos Férricos/uso terapéutico , Hipertermia Inducida/métodos , Neoplasias Hepáticas/terapia , Magnetoterapia/métodos , Nanopartículas/uso terapéutico , Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Citometría de Flujo , Hematínicos/uso terapéutico , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Neoplasias Hepáticas/patología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
3.
Yi Chuan Xue Bao ; 27(9): 792-9, 2000.
Artículo en Chino | MEDLINE | ID: mdl-11132495

RESUMEN

Complete diallel crosses with seven varieties of black pericarp rice were conducted in one year to analyze the genetic effects on main mineral elements of Fe, Zn, Mn and P contents in kernels of parents and their F1S and F2S, using the full genetic model including triploid endosperm, cytoplasmic and maternal effects on quantitative traits of seeds in cereal crops. The results indicated that the contents of all the four mineral elements were controlled by seed direct genetic effects, maternal genetic effects as well as by cytoplasmic effects. The seed direct genetic effects were more important than the maternal genetic effects for Fe, Zn, Mn contents, and seed direct additive effects constituted a major part of their genetic effects, whereas seed direct additive, maternal additive and dominant effects formed the main part in the inheritance of P content. The heritabilities of seed direct effects of the 4 mineral element contents were all highly significant. The estimate values of narrow heritabilites of seed direct genetic effects were high for Fe, Zn and Mn contents, while those of seed and maternal effects were intermediate for P content. Therefore, more attention should be paid to the single plant selection and single grain selection based on the seed mineral element contents of hybrid offspring.


Asunto(s)
Hierro/análisis , Manganeso/análisis , Oryza/genética , Fósforo/análisis , Zinc/análisis , Oryza/química
4.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 16(5): 283-6, 1996 May.
Artículo en Chino | MEDLINE | ID: mdl-9387720

RESUMEN

One hundred and forty-three patients were diagnosed as chronic superficial atrophic gastritis of gastric antrum or with metaplasia by means of gastroscopic observation with pathological biopsy examination. They were divided into 4 types (the Spleen-Stomach Cold-Deficiency type, Disharmonious of Liver and Stomach type, Spleen-Stomach Yin Deficiency type and Spleen Deficiency with Qi-Stagnation type) and subdivided according to treatment into two groups, 75 patients of treatment group of above-mentioned 4 types were treated with Piweiping capsule (PWPC) I, II, III, IV respectively, 68 patients of control group were all treated with Sanjiu Weitai (SJWT). After 3-6 months of treatment, the improvement of gastric mucosa cyclic adenosine monophosphate, deoxyribonucleic acid, 3H-thymopyrimidine nucleoside and lymphocyte transformation of treatment group were all superior to that of control group, P < 0.05-0.001. The curative rate and total effective rate of symptomatic effect of treatment group were 49.3% and 92.0%, while at intestinal metaplasia of treatment group were 45.3% and 62.7%. As in control group, they were 29.4%, 67.6%, 10.3% and 29.4% respectively. The difference between two groups was significant, P < 0.001. These results suggested that the PWPC could reverse the intestinal metaplasia through improving the gastric cAMP, DNA and strengthening the cellular immunity and the effect would be enhanced when the treatment was based on syndrome differentiation.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Mucosa Gástrica/patología , Gastritis Atrófica/tratamiento farmacológico , Adulto , Cápsulas , AMP Cíclico/metabolismo , ADN/metabolismo , Femenino , Mucosa Gástrica/metabolismo , Gastritis Atrófica/metabolismo , Gastritis Atrófica/patología , Humanos , Activación de Linfocitos , Masculino , Metaplasia , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA